Home U.S. regulators reject Sanofi's MS treatment Lemtrada
 

Keywords :   


U.S. regulators reject Sanofi's MS treatment Lemtrada

2014-01-01 22:27:11| Biotech - Topix.net

Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.

Tags: treatment reject regulators sanofis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
13.11Flesh and Blood RF 1
13.118
13.11 PT-800 700C 520mm VINTAGE
13.11
13.11Bost & Bim / The Bombing
13.11Shohei Ohtani 27 Majestic TM
13.11 Z
13.11BBM 2020
More »